Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck Takes Cost-Cutting Therapy, But What Will The Side Effects Be?

Related Content

Synergies Without The Merger: Pfizer Sees $4 Bil. In Cost Cutting By 2008

Apr 11 2005

Merck Taps Clark As CEO In Nod To Medco Heritage; Gilmartin To Retire

May 09 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window